Skip to main content
Clinical Trials/NCT00480103
NCT00480103
Terminated
Phase 3

Multi-Center Evaluation Program NCVD1H Intrauterine Embryo'S Development Assisted by ANECOVA ACVd1 Device

Instituto Valenciano de Infertilidad, IVI VALENCIA1 site in 1 countryAugust 2007
ConditionsHealthy

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Healthy
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Locations
1
Status
Terminated
Last Updated
15 years ago

Overview

Brief Summary

We aim to compare the morphological and chromosomal features of human embryos cultured In Vitro versus those developed in a new In Vivo culture system with encapsulation in utero as well as implantation and pregnancy rate.

Registry
clinicaltrials.gov
Start Date
August 2007
End Date
November 2008
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA

Eligibility Criteria

Inclusion Criteria

  • Women age below 37
  • Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH)
  • Negative serologic screening for HIV, Hep B and C
  • No uterine or ovarian alterations found by ultrasound
  • Normal BMI (19 - 29 kg/m2).

Exclusion Criteria

  • At least 8 stage MII oocytes are not retrieved
  • Endometriosis or PCO
  • Severe male factor in the partner

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials